is retatrutide fda approved october 2025 Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, being sold openly across the internet and prescribed by licensed physicians online and What is retatrutide? | Retatrutide

Mounjaro demonstrates comparable glycemic benefits with more extensive documentation

By the time you reach 8mg, your GI system has adapted through two previous escalation cycles, and a 50% increase is proportionally less disruptive than the doublings at lower levels

Are there any side effects of weight loss drugs

As of early 2026, retatrutide is not FDA approved and cannot be legally prescribed or purchased

14 Both studies were limited by relatively short follow-up among the included trials, narrow systemic inclusion criteria, limited information on baseline diabetic retinopathy status and, most important, inadequate and non-rigorous methodologies for diabetic retinopathy evaluation

Several studies revealed that GLP-1RAs relieve myocardial damage and glucose toxicity by promoting autophagy, which is associated with decreasing mTOR phosphorylation and increasing AMPK phosphorylation [88]